A Gram-negative diplococcus that is both a nasopharyngeal commensal (carried asymptomatically by 10-35% of the population) and a devastating invasive pathogen causing bacterial meningitis and meningococcal septicemia. Its nickel dependency centers on Ni-dependent glyoxalase I (GloI), which supports the high metabolic demands of explosive growth during invasive disease.
Nickel-Dependent Virulence
Ni-Glyoxalase I
- N. meningitidis possesses a confirmed Ni-dependent GloI that detoxifies methylglyoxal, the toxic byproduct of glycolysis [maier 2019 nickel microbial pathogenesis].
- During the transition from commensal carriage to invasive disease, N. meningitidis undergoes rapid proliferation in the bloodstream and CSF. High glycolytic throughput generates methylglyoxal that must be detoxified to sustain growth.
- The Ni-dependent GloI is structurally distinct from human Zn-dependent GloI, making it a potential selective drug target -- particularly relevant for a pathogen where rapid treatment is life-or-death.
- N. gonorrhoeae (the gonococcus) also possesses Ni-GloI, extending this nickel dependency across the genus.
Iron Acquisition
- Iron is the most critical metal for meningococcal virulence. N. meningitidis has multiple iron acquisition systems [patil 2021 infection metallomics critical care]:
- Transferrin-binding proteins (TbpA/TbpB): directly strip iron from host transferrin -- a human-specific adaptation.
- Lactoferrin-binding proteins (LbpA/LbpB): acquire iron from lactoferrin at mucosal surfaces.
- Hemoglobin/haptoglobin receptors (HmbR, HpuAB): access iron from hemoglobin.
- Iron-regulated gene expression is controlled by Fur; iron limitation is a key signal for virulence factor expression.
- The bacterium does not produce classical siderophores, relying instead on direct receptor-mediated piracy of host iron-binding proteins.
Pathogenesis
- Nasopharyngeal colonization: initial attachment via Type IV pili and Opa/Opc adhesins. At this stage, the bacterium lives as a commensal using mucosal iron sources.
- Invasion: breach of the nasopharyngeal epithelium, entry into the bloodstream. Capsular polysaccharide is the primary defense against complement-mediated killing.
- Meningitis: crossing the blood-brain barrier (BBB) via transcellular, paracellular, and possibly Trojan horse mechanisms [patil 2021 infection metallomics critical care]. The CSF is extremely nutrient-poor, making metal acquisition critical.
- Septicemic shock (purpura fulminans): massive endotoxin (LPS) release causes disseminated intravascular coagulation, hemorrhagic skin necrosis, and multi-organ failure.
Clinical Significance
- Bacterial meningitis: case fatality rate 10-15% even with treatment; up to 20% of survivors have permanent sequelae (hearing loss, brain damage, limb amputation).
- Epidemic potential: causes large outbreaks, particularly in the African "meningitis belt." Serogroup A epidemics have been partially controlled by MenAfriVac.
- Serogroups: A, B, C, W, X, Y cause most disease. Vaccines exist for A, C, W, Y (conjugate) and B (protein-based).
- Rapid progression: can kill within hours of symptom onset; empiric treatment (ceftriaxone) must begin immediately on clinical suspicion.
Connections
- glyoxalase -- confirmed Ni-GloI for methylglyoxal detoxification
- nickel -- cofactor for GloI; the Ni-vs-Zn selectivity is key to drug targeting
- iron -- critical for virulence; acquired by pirating host transferrin and lactoferrin
- metal dependent virulence -- Ni-GloI supports rapid growth during invasive disease
- nutritional immunity -- host transferrin/lactoferrin restrict iron; nickel sequestration may limit GloI
- pseudomonas aeruginosa -- another confirmed Ni-GloI pathogen
- yersinia pestis -- shares Ni-GloI dependency for explosive bloodstream growth
- streptococcus pneumoniae -- the other major bacterial meningitis pathogen; iron-dependent